|Last Price||Today's Change||52-Week Range||Trading Volume|
|5.58 CAD||-0.05 (-0.89%)||2.75 - 5.90||21.6 thousand (Below Avg)|
Market data as of 3:58PM 03/04/15. Quotes are delayed by at least 15 min.
Aurinia Pharmaceuticals to Present at Cowen and Company 35th Annual Health Care Conference
Business Wire - Thursday 02/26/2015 6:08 PM ET
Aurinia Pharmaceuticals to Initiate an Open Label Clinical Study to Investigate the Impact of Voclosporin on Lupus Nephritis Biomarkers
Business Wire - Monday 02/09/2015 8:00 AM ET
Company Profile for Aurinia Pharmaceuticals Inc.
Business Wire - Friday 02/06/2015 3:05 PM ET
Aurinia Pharmaceuticals Announces Recently Granted Nanomicellar Formulation Patents in Japan and China for Topical Ophthalmic Administration of voclosporin
Business Wire - Tuesday 02/03/2015 8:06 PM ET
|Revenue Growth (1yr)||--|
|Net Income Growth (1yr)||--|
Data is delayed by at least 15 min.